86 related articles for article (PubMed ID: 17926322)
21. Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity.
Koreen S; Gelman R; Martinez-Perez ME; Jiang L; Berrocal AM; Hess DJ; Flynn JT; Chiang MF
Ophthalmology; 2007 Dec; 114(12):e59-67. PubMed ID: 18054630
[TBL] [Abstract][Full Text] [Related]
22. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
[TBL] [Abstract][Full Text] [Related]
23. [Tumor markers and genetic changes in lung cancer].
Dediu M
Pneumologia; 1999; 48(4):317-20. PubMed ID: 10856995
[No Abstract] [Full Text] [Related]
24. Estimation of the ROC curve under verification bias.
Fluss R; Reiser B; Faraggi D; Rotnitzky A
Biom J; 2009 Jun; 51(3):475-90. PubMed ID: 19588455
[TBL] [Abstract][Full Text] [Related]
25. The linear neuron as marker selector and clinical predictor in cancer gene analysis.
Blazadonakis ME; Zervakis M
Comput Methods Programs Biomed; 2008 Jul; 91(1):22-35. PubMed ID: 18423925
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
[TBL] [Abstract][Full Text] [Related]
27. Use of multidimensional data analysis for prediction of lung malignity.
Mrázová V; Mocák J; Varmusová E; Kavková D; Bednárová A
J Pharm Biomed Anal; 2009 Sep; 50(2):210-5. PubMed ID: 19467816
[TBL] [Abstract][Full Text] [Related]
28. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
[TBL] [Abstract][Full Text] [Related]
29. Erythrocyte and platelet phospholipid fatty acids as markers of advanced non-small cell lung cancer: comparison with serum levels of sialic acid, TPS and Cyfra 21-1.
de Castro J; Rodríguez MC; Martínez-Zorzano VS; Hernández-Hernández A; Llanillo M; Sánchez-Yagüe J
Cancer Invest; 2008 May; 26(4):407-18. PubMed ID: 18443962
[TBL] [Abstract][Full Text] [Related]
30. Identification of melanoma with a gas sensor array.
D'Amico A; Bono R; Pennazza G; Santonico M; Mantini G; Bernabei M; Zarlenga M; Roscioni C; Martinelli E; Paolesse R; Di Natale C
Skin Res Technol; 2008 May; 14(2):226-36. PubMed ID: 18412567
[TBL] [Abstract][Full Text] [Related]
31. Comment on 'The partial area under the summary ROC curve'.
Nadarajah S
Stat Med; 2008 Jun; 27(14):2731-4; author reply 2734-5. PubMed ID: 17910010
[No Abstract] [Full Text] [Related]
32. Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer.
Cortese R; Hartmann O; Berlin K; Eckhardt F
Int J Biochem Cell Biol; 2008; 40(8):1494-508. PubMed ID: 18203646
[TBL] [Abstract][Full Text] [Related]
33. Update on screening for lung cancer.
Midthun DE; Jett JR
Semin Respir Crit Care Med; 2008 Jun; 29(3):233-40. PubMed ID: 18506661
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the predictiveness of a continuous marker.
Huang Y; Sullivan Pepe M; Feng Z
Biometrics; 2007 Dec; 63(4):1181-8. PubMed ID: 17489968
[TBL] [Abstract][Full Text] [Related]
35. Assigning cases to groups using taxometric results: an empirical comparison of classification techniques.
Ruscio J
Assessment; 2009 Mar; 16(1):55-70. PubMed ID: 18607008
[TBL] [Abstract][Full Text] [Related]
36. Indexes for three-class classification performance assessment--an empirical comparison.
Sampat MP; Patel AC; Wang Y; Gupta S; Kan CW; Bovik AC; Markey MK
IEEE Trans Inf Technol Biomed; 2009 May; 13(3):300-12. PubMed ID: 19171528
[TBL] [Abstract][Full Text] [Related]
37. CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis.
Pavićević R; Bubanović G; Franjević A; Stancić-Rokotov D; Samarzija M
Coll Antropol; 2008 Jun; 32(2):485-98. PubMed ID: 18756899
[TBL] [Abstract][Full Text] [Related]
38. Prognostic markers for stage I non-small cell lung cancer.
Ohara G; Satoh H; Hizawa N
Lung Cancer; 2008 Jan; 59(1):137. PubMed ID: 17996327
[No Abstract] [Full Text] [Related]
39. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.
Wu YK; Chen KT; Kuo YB; Huang YS; Chan EC
Cancer Lett; 2009 Jan; 273(2):331-5. PubMed ID: 18824294
[TBL] [Abstract][Full Text] [Related]
40. [Lung cancer: progress in diagnosis and treatment. I. Diagnosis and physiopathology: 4. Progress in the study of tumor markers].
Kuwabara M; Shibata N; Ariyoshi Y
Nihon Naika Gakkai Zasshi; 1997 Jan; 86(1):20-6. PubMed ID: 9102418
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
